arXiv Open Access 2024

Can Personalized Medicine Coexist with Health Equity? Examining the Cost Barrier and Ethical Implications

Kishi Kobe Yee Francisco Andrane Estelle Carnicer Apuhin Myles Joshua Toledo Tan Mickael Cavanaugh Byers Nicholle Mae Amor Tan Maravilla +2 lainnya
Lihat Sumber

Abstrak

Personalized medicine (PM) promises to transform healthcare by providing treatments tailored to individual genetic, environmental, and lifestyle factors. However, its high costs and infrastructure demands raise concerns about exacerbating health disparities, especially between high-income countries (HICs) and low- and middle-income countries (LMICs). While HICs benefit from advanced PM applications through AI and genomics, LMICs often lack the resources necessary to adopt these innovations, leading to a widening healthcare divide. This paper explores the financial and ethical challenges of PM implementation, with a focus on ensuring equitable access. It proposes strategies for global collaboration, infrastructure development, and ethical frameworks to support LMICs in adopting PM, aiming to prevent further disparities in healthcare accessibility and outcomes.

Topik & Kata Kunci

Penulis (7)

K

Kishi Kobe Yee Francisco

A

Andrane Estelle Carnicer Apuhin

M

Myles Joshua Toledo Tan

M

Mickael Cavanaugh Byers

N

Nicholle Mae Amor Tan Maravilla

H

Hezerul Abdul Karim

N

Nouar AlDahoul

Format Sitasi

Francisco, K.K.Y., Apuhin, A.E.C., Tan, M.J.T., Byers, M.C., Maravilla, N.M.A.T., Karim, H.A. et al. (2024). Can Personalized Medicine Coexist with Health Equity? Examining the Cost Barrier and Ethical Implications. https://arxiv.org/abs/2411.02307

Akses Cepat

Lihat di Sumber
Informasi Jurnal
Tahun Terbit
2024
Bahasa
en
Sumber Database
arXiv
Akses
Open Access ✓